Journal of AIDS & Clinical Research

ISSN: 2155-6113

Open Access

HIV-1 Capsid as a Target for Antiviral Therapy


Zhiqing Zhang, Feng Zhang, Chao Yang, Jialong Qi, Shuangquan Gao, Shaowei Li, Ying Gu and Ningshao Xia

Highly active anti-retroviral therapy (HAART) is the mainstay anti-HIV-1 therapy as it prolongs survival and switches HIV-1 infection from a fatal disease to a chronic yet manageable one. Unfortunately, drug toxicity and the emergence of drug-resistant mutant strains in patients undergoing long-term therapy have meant that there is still a continual need for novel drugs that target alternative molecules in the HIV-1 life cycle. The HIV-1 Gag precursor protein is a multidomain polyprotein that is proteolytically cleaved into the main, mature capsid protein; CA. CA has multifaceted roles during HIV-1 morphogenesis and is thus regarded as a promising target for future antiviral intervention. In this review, we describe the advances made in our understanding of the HIV-1 capsid structure and the key interactions involved during core assembly, and discuss how this and future knowledge will provide important structural insight for antiviral design.


Share this article

Google Scholar citation report
Citations: 5061

Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report

Journal of AIDS & Clinical Research peer review process verified at publons

Indexed In

arrow_upward arrow_upward